Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bivalirudin vs Heparin in STE-ACS (EUROMAX)
NCT01087723Phase 3Completed
- Sponsor
- The Medicines Company
- Start
- Mar 2010
- Primary completion
- Aug 2013
- Countries
- 9
01
Overview
A Phase 3 trial of bivalirudin in ST-elevation myocardial infarction (STEMI), sponsored by The Medicines Company. Started Mar 2010; status: completed.
02
Drugs
bivalirudin
03
Conditions
ST-elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT01087723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01087723.